|
Sign In to gain access to subscriptions and/or personal tools.
|
Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity
F. Russell Westwood,
Alison Bigley,
Kevin Randall,
Alan M. Marsden and
Robert C. Scott
Safety Assessment, AstraZeneca, Macclesfield, Cheshire, SK10 4TG, United Kingdom
Correspondence: Address correspondence to: F. Russell Westwood, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom; e-mail:russell.westwood{at}astrazeneca.com
Simvastatin and cerivastatin have been used to investigate the development of statin-induced muscle necrosis in the rat. This was similar for both statins and was treatment-duration dependent, only occurring after 10 days had elapsed even if the dose was increased, and still occurring after this time when dosing was terminated earlier as a result of morbidity. It was then widespread and affected all areas of the muscular system. However, even when myotoxicity was severe, particular individual muscles and some types of fibres within affected muscles were spared consistently. Fibre typing of spared muscles and of acutely necrotic fibres within affected muscles indicated a differential fibre sensitivity to statin-induced muscle necrosis. The fibres showed a necrotic response to statin administration that matched their oxidative/glycolytic metabolic nature: Least sensitive  I  IIA IID IIB  most sensitive. Type I and IIB fibres represent metabolic extremes of a continuum of metabolic properties through the fibre types with type I fibres most oxidative in metabolism and type IIB fibres most glycolytic. In addition, in some (nonnecrotic) glycolytic fibres from muscles showing early multifocal single fibre necrosis the only subcellular alterations present in isolation of any other changes were mitochondrial. These changes were characterised by an increased incidence of vacuolation and the formation of myelinoid vesicular bodies that accumulated in the subsarcolemmal areas. These findings suggest an important early involvement of mitochondria in selective glycolytic muscle fibre necrosis following inhibition of the enzyme HMG-CoA reductase.
Key Words: Statin • muscle • necrosis • rat • development • type • fast-twitch • slow-twitch
Toxicologic Pathology, Vol. 33, No. 2,
246-257 (2005)
DOI: 10.1080/01926230590908213
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. E. Mallinson, D. Constantin-Teodosiu, J. Sidaway, F. R. Westwood, and P. L. Greenhaff
Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy
J. Physiol.,
January 1, 2009;
587(1):
219 - 230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sathasivam and B. Lecky
Statin induced myopathy
BMJ,
November 6, 2008;
337(nov06_3):
a2286 - a2286.
[Full Text]
|
|
|
|
|
|
|
M. L. Pritt, D. G. Hall, J. Recknor, K. M. Credille, D. D. Brown, N. P. Yumibe, A. E. Schultze, and D. E. Watson
Fabp3 as a Biomarker of Skeletal Muscle Toxicity in the Rat: Comparison with Conventional Biomarkers
Toxicol. Sci.,
June 1, 2008;
103(2):
382 - 396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Dykens, J. D. Jamieson, L. D. Marroquin, S. Nadanaciva, J. J. Xu, M. C. Dunn, A. R. Smith, and Y. Will
In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone
Toxicol. Sci.,
June 1, 2008;
103(2):
335 - 345.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Madsen, E. Janovitz, R. Zhang, Van Nguyen-Tran, C. S. Ryan, X. Yin, H. Monshizadegan, M. Chang, C. D'Arienzo, S. Scheer, et al.
The Guinea Pig as a Preclinical Model for Demonstrating the Efficacy and Safety of Statins
J. Pharmacol. Exp. Ther.,
February 1, 2008;
324(2):
576 - 586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. R. Westwood, R. C. Scott, A. M. Marsden, A. Bigley, and K. Randall
Rosuvastatin: Characterization of Induced Myopathy in the Rat
Toxicol Pathol,
February 1, 2008;
36(2):
345 - 352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
